![Richard Dugan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Dugan
Directeur/Bestuurslid bij
VANDA PHARMACEUTICALS INC.
Vermogen: 1 M $ op 31-05-2026
Profiel
Richard W.
Dugan is Lead Independent Director at Vanda Pharmaceuticals, Inc. since 2022.
Formerly, Mr. Dugan was Director at Middlebrook Pharmaceuticals, Inc. from 2003 to 2010, Director at Critical Therapeutics, Inc. from 2004 to 2008, Director at Antisoma, Inc., and Senior Partner at Ernst & Young LLP from 2001 to 2002.
Mr. Dugan completed undergraduate studies at The Pennsylvania State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-06-2026 | 177.454 ( 0,3% ) | 1 M $ | 31-05-2026 |
Actieve functies van Richard Dugan
| Bedrijven | Functie | Begin |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Directeur/Bestuurslid | 01-12-2005 |
Eerdere bekende functies van Richard Dugan
| Bedrijven | Functie | Einde |
|---|---|---|
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Directeur/Bestuurslid | 03-08-2010 |
Critical Therapeutics, Inc.
 Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Directeur/Bestuurslid | 04-11-2008 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01-09-2002 |
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceuticals | Directeur/Bestuurslid | - |
Opleiding van Richard Dugan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
95
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Health Technology |
Critical Therapeutics, Inc.
Critical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes products for respiratory, inflammatory and critical care diseases | Health Technology |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Antisoma, Inc.
Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceuticals | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
